用于常规诊疗的幼年皮肌炎肌力混合测量工具的开发与测试
开发并测试基于MMT-8全部8项与CMAS中3项(抬头时间、腹肌评估、仰卧起坐)组成的混合肌力测量工具hMC,评分0-100分,100分表示肌力正常。在3个跨国样本共810例幼年皮肌炎患者中验证,显示良好的结构效度、重测信度(ICC=0.99)、内部一致性(Cronbach's α=0.94)、对临床变化的反应性(标准化反应均数=0.8)及区分能力(P<0.001)。
要点
- hMC由MMT-8全部8项与CMAS中3项(抬头时间、腹肌评估、仰卧起坐)组成,评分0-100分。
- 在810例幼年皮肌炎患者中验证,重测信度ICC=0.99,内部一致性Cronbach's α=0.94。
- 对医师判断为改善的患者标准化反应均数=0.8,区分疾病活动状态及家长满意度P<0.001。
核心结论
- hMC在疾病活动度和严重程度范围广泛的大样本幼年皮肌炎患者中具有良好的测量性能。
- 该新工具主要拟用于常规临床诊疗,应在其他患者人群中前瞻性进一步测试。
研究设计与样本
- 开发并测试幼年皮肌炎肌力混合测量工具hMC,由MMT-8全部8项与CMAS中3项(抬头时间、腹肌评估、仰卧起坐)组成。
- hMC评分范围0-100分,100分表示肌力正常。
- 验证过程使用3个大型跨国患者样本,共纳入810例幼年皮肌炎患者。
主要发现
- hMC具有表面效度和内容效度。
- hMC具有良好结构效度、优良的重测信度(组内相关系数=0.99)和内部一致性(Cronbach's α=0.94)。
- 对随时间变化的临床改变具有强反应性,在医师判断为改善的患者中标准化反应均数=0.8。
- 能满意区分医师判断为疾病不活动或低、中、高疾病活动状态的患者(P<0.001)。
- 能满意区分家长对疾病过程满意或不满意的患者(P<0.001)。
关键数值与推荐
- hMC评分范围0-100分,100分表示肌力正常。
- 重测信度组内相关系数=0.99。
- 内部一致性Cronbach's α=0.94。
- 医师判断为改善的患者中标准化反应均数=0.8。
- 区分医师判断疾病活动状态及家长满意度的P值均<0.001。
临床怎么用
- hMC主要拟用于常规临床诊疗。
- 作者认为应在其他患者人群中前瞻性进一步测试该工具。
局限性
- 原文结论提出该工具应在其他患者人群中前瞻性进一步测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and test a hybrid measure of muscle strength for juvenile dermatomyositis (JDM), which is based on the combination of the Manual Muscle Testing in 8 muscles (MMT-8) and the Childhood Myositis Assessment Scale (CMAS) but is more comprehensive than the former and more feasible than the latter. METHODS: The hybrid MMT-8/CMAS (hMC) is composed of all 8 items of the MMT-8 and 3 items of the CMAS: time of head lift, assessment of abdominal muscles, and floor rise. The score ranges 0-100, with 100 indicating normal muscle strength. Validation procedures were conducted using 3 large multinational patient samples, including a total of 810 JDM patients. RESULTS: The hMC revealed face and content validity, good construct validity, excellent test-retest reliability (intraclass correlation coefficient = 0.99), and internal consistency (Cronbach's α = 0.94), strong responsiveness to clinical change over time (standardized response mean = 0.8 among patients judged as improved by the caring physician), and satisfactory capacity to discriminate patients judged as being in the states of inactive disease or low, moderate, or high disease activity by the physician (P < 0.001) or patients whose parents were satisfied or not satisfied with the illness course (P < 0.001). CONCLUSION: The hMC was found to possess good measurement properties in a large population of patients with a wide range of disease activity and severity. The new tool, which is primarily intended for use in routine clinical care, should be further tested in other populations of patients evaluated prospectively.
引用
- Varnier GC, Rosina S, Ferrari C, et al. Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care. Arthritis Care Res (Hoboken). 2018. PMID: 29245175. doi:10.1002/acr.23491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。